Difference between revisions of "TFE3-rearranged renal cell carcinoma"

TFE3-rearranged renal cell carcinoma (view source)

420 bytes added , 23:10, 1 October 2014

48,466

edits

@@ Line 33: / Line 33: @@
 *Defined by the presence of a fusion gene formed with TFE3 @ Xp11.2.
 *TFE3 is the gene involved in the translocation seen in [[alveolar soft part sarcoma]] (ASPS).
-*Poor prognosis ~ 50% present at stage IV, majority of [[lymph node metastases]].
+*Poor prognosis - majority Stage III or Stage IV.<ref name=pmid25002378>{{Cite journal  | last1 = Su | first1 = HH. | last2 = Sung | first2 = MT. | last3 = Chiang | first3 = PH. | last4 = Cheng | first4 = YT. | last5 = Chen | first5 = YT. | title = The preliminary experiences of translocation renal cell carcinoma and literature review. | journal = Kaohsiung J Med Sci | volume = 30 | issue = 8 | pages = 402-8 | month = Aug | year = 2014 | doi = 10.1016/j.kjms.2014.03.003 | PMID = 25002378 }}</ref>
 *~1/3 of childhood RCC.<ref name=pmid17667536>{{Cite journal  | last1 = Argani | first1 = P. | last2 = Olgac | first2 = S. | last3 = Tickoo | first3 = SK. | last4 = Goldfischer | first4 = M. | last5 = Moch | first5 = H. | last6 = Chan | first6 = DY. | last7 = Eble | first7 = JN. | last8 = Bonsib | first8 = SM. | last9 = Jimeno | first9 = M. | title = Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. | journal = Am J Surg Pathol | volume = 31 | issue = 8 | pages = 1149-60 | month = Aug | year = 2007 | doi = 10.1097/PAS.0b013e318031ffff | PMID = 17667536 }}</ref>